• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Fatty acid-induced production of plasminogen activator inhibitor-1 by adipose macrophages is greater in middle-aged versus younger adult participants.脂肪组织巨噬细胞受脂肪酸诱导生成纤溶酶原激活物抑制剂-1的能力在中年参与者中大于年轻成年参与者。
J Gerontol A Biol Sci Med Sci. 2012 Dec;67(12):1321-8. doi: 10.1093/gerona/gls200. Epub 2012 Oct 22.
2
Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages.脂肪细胞衍生因子增强巨噬细胞对营养物诱导的纤溶酶原激活物抑制剂-1 的产生。
Sci Transl Med. 2010 Feb 24;2(20):20ra15. doi: 10.1126/scitranslmed.3000292.
3
Are free fatty acids related to plasma plasminogen activator inhibitor 1 in android obesity?在男性型肥胖中,游离脂肪酸与血浆纤溶酶原激活物抑制剂1有关吗?
Int J Obes Relat Metab Disord. 1995 Nov;19(11):836-8.
4
Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects.非糖尿病和2型糖尿病患者皮下脂肪组织中纤溶酶原激活物抑制剂-1(PAI-1)的表达
Diabetes Metab Res Rev. 2000 Sep-Oct;16(5):364-9. doi: 10.1002/1520-7560(2000)9999:9999<::aid-dmrr148>3.0.co;2-c.
5
Synergistic augmentation of expression of plasminogen activator inhibitor type-1 induced by insulin, very-low-density lipoproteins, and fatty acids.胰岛素、极低密度脂蛋白和脂肪酸协同增强纤溶酶原激活物抑制剂1型的表达。
Coron Artery Dis. 1996 Nov;7(11):813-7. doi: 10.1097/00019501-199611000-00004.
6
Relationship between adipose tissue lipolytic activity and skeletal muscle insulin resistance in nondiabetic women.非糖尿病女性脂肪组织脂解活性与骨骼肌胰岛素抵抗的关系。
J Clin Endocrinol Metab. 2012 Jul;97(7):E1219-23. doi: 10.1210/jc.2012-1035. Epub 2012 Apr 6.
7
Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease.肥胖和非酒精性脂肪性肝病患者的脂肪组织免疫学、炎症、外泌体与胰岛素敏感性的关系。
Gastroenterology. 2021 Sep;161(3):968-981.e12. doi: 10.1053/j.gastro.2021.05.008. Epub 2021 May 15.
8
Aging per se increases the susceptibility to free fatty acid-induced insulin resistance.衰老本身会增加对游离脂肪酸诱导的胰岛素抵抗的易感性。
J Gerontol A Biol Sci Med Sci. 2010 Aug;65(8):800-8. doi: 10.1093/gerona/glq078. Epub 2010 May 26.
9
Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.肥胖与纤维蛋白溶解功能受损:脂肪组织产生纤溶酶原激活物抑制剂-1的作用
Int J Obes Relat Metab Disord. 2004 Nov;28(11):1357-64. doi: 10.1038/sj.ijo.0802778.
10
Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.曲格列酮对2型糖尿病患者以及瘦型和肥胖型正常受试者纤溶酶原激活物抑制剂1血药浓度的影响。
Diabetes. 2000 Apr;49(4):633-9. doi: 10.2337/diabetes.49.4.633.

引用本文的文献

1
Aging adipose tissue, insulin resistance, and type 2 diabetes.衰老的脂肪组织、胰岛素抵抗和 2 型糖尿病。
Biogerontology. 2024 Feb;25(1):53-69. doi: 10.1007/s10522-023-10067-6. Epub 2023 Sep 19.
2
Relationships between Rodent White Adipose Fat Pads and Human White Adipose Fat Depots.啮齿动物白色脂肪垫与人类白色脂肪储存部位之间的关系。
Front Nutr. 2016 Apr 19;3:10. doi: 10.3389/fnut.2016.00010. eCollection 2016.
3
Effect of photoperiod on the feline adipose transcriptome as assessed by RNA sequencing.通过RNA测序评估光周期对猫脂肪转录组的影响。
BMC Vet Res. 2014 Jul 3;10:146. doi: 10.1186/1746-6148-10-146.
4
Insulin sensitizing and anti-inflammatory effects of thiazolidinediones are heightened in obese patients.噻唑烷二酮类药物具有胰岛素增敏和抗炎作用,在肥胖患者中作用增强。
J Investig Med. 2013 Dec;61(8):1152-60. doi: 10.2310/JIM.0000000000000017.

本文引用的文献

1
Xylitol prevents NEFA-induced insulin resistance in rats.木糖醇可预防 NEFA 诱导的大鼠胰岛素抵抗。
Diabetologia. 2012 Jun;55(6):1808-12. doi: 10.1007/s00125-012-2527-z. Epub 2012 Mar 30.
2
Visceral fat cell lipolysis and cardiovascular risk factors in obesity.肥胖症内脏脂肪细胞脂解作用与心血管危险因素。
Horm Metab Res. 2011 Oct;43(11):809-15. doi: 10.1055/s-0031-1287767. Epub 2011 Oct 18.
3
Fat tissue, aging, and cellular senescence.脂肪组织、衰老与细胞衰老。
Aging Cell. 2010 Oct;9(5):667-84. doi: 10.1111/j.1474-9726.2010.00608.x. Epub 2010 Aug 15.
4
Lipid-induced insulin resistance: unravelling the mechanism.脂毒性诱导的胰岛素抵抗:机制解析。
Lancet. 2010 Jun 26;375(9733):2267-77. doi: 10.1016/S0140-6736(10)60408-4.
5
Aging per se increases the susceptibility to free fatty acid-induced insulin resistance.衰老本身会增加对游离脂肪酸诱导的胰岛素抵抗的易感性。
J Gerontol A Biol Sci Med Sci. 2010 Aug;65(8):800-8. doi: 10.1093/gerona/glq078. Epub 2010 May 26.
6
Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages.脂肪细胞衍生因子增强巨噬细胞对营养物诱导的纤溶酶原激活物抑制剂-1 的产生。
Sci Transl Med. 2010 Feb 24;2(20):20ra15. doi: 10.1126/scitranslmed.3000292.
7
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.糖化血红蛋白、糖尿病与非糖尿病成年人的心血管风险。
N Engl J Med. 2010 Mar 4;362(9):800-11. doi: 10.1056/NEJMoa0908359.
8
Aging and regional differences in fat cell progenitors - a mini-review.脂肪细胞祖细胞的衰老与区域差异——综述
Gerontology. 2011;57(1):66-75. doi: 10.1159/000279755. Epub 2010 Jan 29.
9
Effects of meal size and composition on incretin, alpha-cell, and beta-cell responses.膳食大小和组成对肠促胰岛素、α 细胞和 β 细胞反应的影响。
Metabolism. 2010 Apr;59(4):502-11. doi: 10.1016/j.metabol.2009.07.039. Epub 2009 Oct 28.
10
PAI-1 and the metabolic syndrome: links, causes, and consequences.纤溶酶原激活物抑制剂-1与代谢综合征:联系、成因及后果
Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2200-7. doi: 10.1161/01.ATV.0000242905.41404.68. Epub 2006 Aug 24.

脂肪组织巨噬细胞受脂肪酸诱导生成纤溶酶原激活物抑制剂-1的能力在中年参与者中大于年轻成年参与者。

Fatty acid-induced production of plasminogen activator inhibitor-1 by adipose macrophages is greater in middle-aged versus younger adult participants.

机构信息

Diabetes Research and Training Center, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Belfer 709, Bronx, NY 10461, USA.

出版信息

J Gerontol A Biol Sci Med Sci. 2012 Dec;67(12):1321-8. doi: 10.1093/gerona/gls200. Epub 2012 Oct 22.

DOI:10.1093/gerona/gls200
PMID:23089338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3670154/
Abstract

BACKGROUND

Human aging is associated with heightened risk of diabetes and cardiovascular disease. Increased fat mass may contribute to age-related diseases by harboring inflammatory macrophages that produce metabolically important proteins such as plasminogen activator inhibitor-1 (PAI-1). Elevated PAI-1 concentrations have been implicated in the pathogenesis of such aging-related conditions as insulin resistance, obesity, and atherosclerosis. We have previously reported that increased plasma free fatty acid (FFA) concentrations augment both circulating PAI-1 concentrations and PAI-1 production by adipose tissue macrophages (ATMs).

METHODS

Because increasing age is associated with increased infiltration and reactivity of adipose macrophages, we performed euglycemic-hyperinsulinemic clamp studies and adipose tissue biopsies with and without elevated FFA concentrations in 31 nondiabetic participants stratified by age, to determine whether middle-aged individuals manifest heightened insulin resistance and PAI-1 production by ATMs in response to elevated nutrient signals relative to their young adult peers.

RESULTS

We observed that elevating FFA concentrations under euglycemic-hyperinsulinemic clamp conditions induced the same degree of insulin resistance in both middle-aged and younger body mass index-matched adults, whereas systemic PAI-1 concentrations were significantly increased in the middle-aged group. Likewise, elevated FFA and insulin concentrations induced larger increases in PAI-1 gene expression in the whole fat and ATMs of middle-aged compared with younger adult participants.

CONCLUSIONS

These studies reveal a heightened adipose inflammatory response to increased FFA and insulin availability in middle-aged individuals relative to younger adults, suggesting that increased susceptibility to the effects of fatty acid excess may contribute to the pathogenesis of age-related diseases.

摘要

背景

人类衰老与糖尿病和心血管疾病风险增加有关。脂肪量的增加可能通过容纳产生代谢重要蛋白(如纤溶酶原激活物抑制剂-1(PAI-1)的炎性巨噬细胞而导致与年龄相关的疾病。升高的 PAI-1 浓度与胰岛素抵抗、肥胖和动脉粥样硬化等与衰老相关的病症的发病机制有关。我们之前报道过,增加血浆游离脂肪酸(FFA)浓度会增加循环 PAI-1 浓度和脂肪组织巨噬细胞(ATMs)产生的 PAI-1。

方法

由于年龄增长与脂肪巨噬细胞的浸润和反应性增加有关,我们在 31 名非糖尿病参与者中进行了正常血糖高胰岛素钳夹研究和脂肪组织活检,这些参与者按年龄分层,有或没有升高的 FFA 浓度,以确定中年个体是否表现出对升高的营养信号的更高胰岛素抵抗和 ATMs 产生 PAI-1,与他们的年轻成年同龄人相比。

结果

我们观察到,在正常血糖高胰岛素钳夹条件下升高 FFA 浓度会导致中年和年轻体重指数匹配成年人的胰岛素抵抗程度相同,而中年组的全身 PAI-1 浓度显著升高。同样,升高的 FFA 和胰岛素浓度会诱导中年参与者的整个脂肪和 ATMs 中 PAI-1 基因表达的更大增加。

结论

这些研究揭示了中年个体相对于年轻成年人对升高的 FFA 和胰岛素可用性的脂肪炎症反应增强,表明对脂肪酸过量影响的易感性增加可能导致与年龄相关的疾病的发病机制。